CXCL8 and chronic obstructive pulmonary disease: The application of bioinformatics tools to identify altered pathways in PBMCs from COPD patients suggested that IL-8 and inducible T cell costimulator (iCOS)-iCOS ligand (iCOSL) signaling were primarily involved in disease progression [37].